FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
-10.02%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$10.9B
AUM Growth
+$10.9B
(-16%)
Cap. Flow
-$295M
Cap. Flow
% of AUM
-2.7%
Top 10 Holdings %
Top 10 Hldgs %
45.56%
Holding
134
New
16
Increased
36
Reduced
22
Closed
31
Top Buys
| 1 |
Centene
CNC
|
$431M |
| 2 |
AGN
Allergan plc
AGN
|
$232M |
| 3 |
IQVIA
IQV
|
$203M |
| 4 |
General Dynamics
GD
|
$146M |
| 5 |
Fidelity National Information Services
FIS
|
$138M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$793M |
| 2 |
MDCO
Medicines Co
MDCO
|
$282M |
| 3 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
$236M |
| 4 |
S&P Global
SPGI
|
$175M |
| 5 |
AXE
Anixter International Inc
AXE
|
$84.5M |
Sector Composition
| 1 | Healthcare | 55.19% |
| 2 | Communication Services | 13.23% |
| 3 | Technology | 11.68% |
| 4 | Industrials | 5.78% |
| 5 | Financials | 4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $1.65B | 14.14% | 9,300,000 +1,310,000 | +16% | +$232M |
|
|
2
Fidelity National Information Services
FIS
$36.5B
| $562M | 4.83% | 4,621,208 +1,135,451 | +33% | +$138M |
|
|
3
Centene
CNC
$14.3B
| $431M | 3.7% | +7,250,000 | New | +$431M |
|
|
4
IQVIA
IQV
$32.4B
| $403M | 3.46% | 3,739,696 +1,885,009 | +102% | +$203M |
|
5
Thermo Fisher Scientific
TMO
$186B
| $353M | 3.03% | 1,243,215 +390,055 | +46% | +$111M |
|
6
Alphabet (Google) Class C
GOOG
$2.58T
| $343M | 2.95% | 295,173 +20,270 | +7% | +$23.6M |
|
7
Charter Communications
CHTR
$36.3B
| $316M | 2.71% | 723,328 +40,235 | +6% | +$17.6M |
|
8
IAC Inc
IAC
$2.94B
| $307M | 2.64% | 1,715,000 -351,500 | -17% | -$63M |
|
9
AbbVie
ABBV
$372B
| $305M | 2.62% | 4,000,000 +1,500,000 | +60% | +$114M |
|
10
Wabtec
WAB
$33.1B
| $304M | 2.61% | 6,322,354 +1,253,167 | +25% | +$60.3M |
|
|
INFO
11
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $296M | 2.54% | 4,925,538 +2,181,988 | +80% | +$131M |
|
12
Microsoft
MSFT
$3.77T
| $288M | 2.47% | 1,823,720 -362,070 | -17% | -$57.1M |
|
13
Visa
V
$683B
| $284M | 2.44% | 1,763,268 +240,808 | +16% | +$38.8M |
|
14
Elevance Health
ELV
$71.8B
| $284M | 2.44% | 1,250,000 | – | – |
|
|
15
General Dynamics
GD
$87.3B
| $276M | 2.37% | 2,083,681 +1,102,316 | +112% | +$146M |
|
16
Sherwin-Williams
SHW
$91.2B
| $234M | 2.01% | 509,130 +141,355 | +38% | +$65M |
|
17
Salesforce
CRM
$245B
| $232M | 2% | 1,614,488 -110,392 | -6% | -$15.9M |
|
18
Cigna
CI
$80.3B
| $221M | 1.9% | 1,250,000 -250,000 | -17% | -$44.3M |
|
19
Alibaba
BABA
$322B
| $218M | 1.88% | 1,123,500 -9,000 | -0.8% | -$1.75M |
|
|
XLRN
20
DELISTED
Acceleron Pharma Inc.
XLRN
| $195M | 1.68% | 2,175,000 +175,000 | +9% | +$15.7M |
|
21
Meta Platforms (Facebook)
META
$1.86T
| $181M | 1.56% | 1,087,524 +57,211 | +6% | +$9.54M |
|
22
Equinix
EQIX
$76.9B
| $176M | 1.51% | 281,933 -134,390 | -32% | -$83.9M |
|
23
Exelixis
EXEL
$10.1B
| $172M | 1.48% | 10,000,000 +2,500,000 | +33% | +$43.1M |
|
24
Iovance Biotherapeutics
IOVA
$807M
| $172M | 1.48% | 5,750,000 -500,000 | -8% | -$15M |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $163M | 1.4% | 1,500,000 +50,000 | +3% | +$5.44M |
|